Chi Advisors LLC Vectiv Bio Holding Ag Transaction History

Chi Advisors LLC

$203 Million
Q3 2023

Shares

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2023 Aug 11, 2023	SELL	$8.29 - $16.97 $20.5 Million - $42 Million	-2,472,728 Reduced 47.05%	2,782,756 $46.9 Million
Q1 2023 May 11, 2023	SELL	$7.34 - $9.15 $1.74 Million - $2.17 Million	-237,409 Reduced 4.32%	5,255,484 $44.7 Million
Q4 2022 Feb 13, 2023	BUY	$7.79 - $8.98 $10.7 Million - $12.3 Million	1,373,321 Added 33.34%	5,492,893 $47.6 Million
Q3 2022 Nov 09, 2022	BUY	$4.7 - $6.07 $1.59 Million - $2.05 Million	337,373 Added 8.92%	4,119,572 $24.7 Million
Q2 2022 Aug 12, 2022	BUY	$4.2 - $6.55 $2.93 Million - $4.57 Million	697,889 Added 22.63%	3,782,199 $20.4 Million
Q1 2022 May 16, 2022	BUY	$4.6 - $5.8 $1.88 Million - $2.37 Million	408,902 Added 15.28%	3,084,310 $14.5 Million
Q4 2021 Feb 11, 2022	BUY	$2.83 - $7.26 $234,340 - $601,171	82,806 Added 3.19%	2,675,408 $13.1 Million
Q3 2021 Nov 15, 2021	BUY	$6.7 - $11.54 $44,327 - $76,348	6,616 Added 0.26%	2,592,602 $20 Million
Q2 2021 Aug 11, 2021	BUY	$11.66 - $24.23 $30.2 Million - $62.7 Million	2,585,986 New	2,585,986 $30.2 Million

Others Institutions Holding VECT

# of Institutions

1

Shares Held

510K

Call Options Held

0

Put Options Held

0

Regency Capital Management Inc.\De

510K
Shares

$0
0.0% of portfolio

About VectivBio Holding AG

Ticker VECT
Exchange NASDAQ
Description
VectivBio Holding AG, a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for treatments of severe rare conditions. It develops apraglutide, a long-acting synthetic peptide analog of glucagon-like peptide-2 that is in Phase III clinical trial for the treatment of patients with sho...

More about VECT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chi Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chi Advisors LLC with notifications on news.